Literature DB >> 23898913

Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome.

M F Sales1, M O Sóter, A L Candido, A P Fernandes, F R Oliveira, A C S Ferreira, M O Sousa, C N Ferreira, K B Gomes.   

Abstract

Polycystic Ovary Syndrome (PCOS) is the most common cause of subfertility associated to metabolic disorders. The aim of this study was to correlate metabolic and proinflammatory factors in women with PCOS. The frequency of Plasminogen Activator Inhibitor-1 (PAI-1) promoter 4 G/5 G polymorphism was also compared to healthy controls. We evaluated 79 PCOS and 79 healthy women. PAI-1 levels are positively correlated with proinflammatory factors in PCOS group. 4 G allele in PAI-1 gene was more frequent in PCOS and the 4G/4 G genotype was associated with increased PAI-1 levels. A correlation between insulin resistance and proinflammatory and overweight was also observed. C-reactive protein, serum levels of vascular cell adhesion molecule-1 (sVCAM-1), Lipid Accumulation Product (LAP) and vitamin D are good tools to evaluated factors associated to cardiovascular risk in women with PCOS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23898913     DOI: 10.3109/09513590.2013.819086

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  5 in total

1.  Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis.

Authors:  Ying Liu; Mei-Guo Sun; Rong Jiang; Rui Ding; Zhen Che; Yan-Yan Chen; Ci-Jiang Yao; Xiao-Xia Zhu; Ji-Yu Cao
Journal:  J Assist Reprod Genet       Date:  2014-01-17       Impact factor: 3.412

2.  Polycystic ovary syndrome: clinical and laboratory variables related to new phenotypes using machine-learning models.

Authors:  A A Veloso; K B Gomes; I S Silva; C N Ferreira; L B X Costa; M O Sóter; L M L Carvalho; J de C Albuquerque; M F Sales; A L Candido; F M Reis
Journal:  J Endocrinol Invest       Date:  2021-09-15       Impact factor: 4.256

Review 3.  Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.

Authors:  Yao Ye; Aurelia Vattai; Xi Zhang; Junyan Zhu; Christian J Thaler; Sven Mahner; Udo Jeschke; Viktoria von Schönfeldt
Journal:  Int J Mol Sci       Date:  2017-07-29       Impact factor: 5.923

Review 4.  Cardiometabolic risk in polycystic ovary syndrome.

Authors:  Katica Bajuk Studen; Marija Pfeifer
Journal:  Endocr Connect       Date:  2018-05-29       Impact factor: 3.335

Review 5.  Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs.

Authors:  Michele d'Angelo; Vanessa Castelli; Maria Grazia Tupone; Mariano Catanesi; Andrea Antonosante; Reyes Dominguez-Benot; Rodolfo Ippoliti; Anna Maria Cimini; Elisabetta Benedetti
Journal:  Int J Mol Sci       Date:  2019-10-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.